Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
World Health Organization.
Constitution of World Health Organization, Annex I. En: WHO, editor. Ten years of the World Health Organization.
[2.]
H. Schipper, J. Clinch, V. Powell.
Definitions and conceptual issues. Quality of life assessments in clinical trials.
pp. 11-25
[3.]
A.J. Carr, B. Gibson, P.G. Robinson.
Is quality of life determined by expectations or experience?.
BMJ, 322 (2001), pp. 1240-1243
[4.]
J.C. Anguita, J.R. Repullo, J. Pereira.
Medidas de calidad de vida relacionada con la salud. Conceptos básicos, construcción y adaptación cultural.
Med Clin (Barc), 116 (2001), pp. 789-796
[5.]
S.M. Hunt, J. Alonso, D. Bucquet, M. Niero, I. Wiklund, S. McKenna.
Cross-cultural adaptation of health measures.
Health Policy, 19 (1991), pp. 33-34
[6.]
X. Badía.
Sobre la adaptación transcultural de medidas de la calidad de vida relacionada con la salud para su uso en España.
Med Clin (Barc), 105 (1995), pp. 56-58
[7.]
A. Mitchell, G. Guyatt, J. Singer, E.J. Irvine.
Quality of life in patients with inflammatory bowel disease.
J Clin Gastroenterol, 10 (1988), pp. 306-310
[8.]
G. Guyatt, A. Mitchell, E.J. Irvine, J. Singer, N. Williams, R. Goodacre, et al.
A new measure of health status for clinical trials in inflammatory bowel disease.
Gastroenterology, 96 (1989), pp. 804-810
[9.]
E.J. Irvine, B. Feagan, J. Rochon, A. Archambault, R.N. Fedorak, A. Groll, et al.
Quality of life: a valid and reliable measure of therapeutic efficady in the treatment of inflammatory bowel disease.
Gastroenterology, 106 (1994), pp. 287-296
[10.]
M.G. Russel, C.J. Pastoor, S. Brandon, J. Rijken, L.G. Engels, D.M. van der Heijde, et al.
Validation of the Dutch translation of the inflammatory bowel disease questionnaire (IBDQ): a health- related quality of life questionnaire in inflammatory bowel disease.
Digestion, 58 (1997), pp. 282-288
[11.]
W. Cheung, A.M. Garratt, I.T. Russell, J.G. Willians.
The UK IBDQ-A British version of the inflammatory bowel disease questionnaire: development and validation.
J Clin Epidemiol, 53 (2000), pp. 297-306
[12.]
A.G. Pallis, I.G. Vlachonikolis, I.A. Mouzas.
Quality of life of Greek patients with inflammatory bowel disease.
Digestion, 63 (2001), pp. 240-246
[13.]
H. Hjortswang, G. Järnerot, B. Curman, H. Sandberg-Gertzén, C. Tysk, B. Blomberg, et al.
Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis.
Scand J Gastroenterol, 36 (2001), pp. 77-85
[14.]
R.W. Leong, Y.T. Lee, J.J. Sung.
Quality of life in Chinese patients with inflammatory bowel disease: validation of the Chinese translation of the inflammatory bowel disease questionnaire.
Aliment Pharmacol Ther, 17 (2003), pp. 711-718
[15.]
J.R. Love, E.J. Irvine, R.N. Fedorak.
Quality of life in inflammatory bowel disease.
J Clin Gastroenterol, 14 (1992), pp. 15-19
[16.]
E.J. Irvine, Q. Zhou, A.K. Thompson.
The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease.
Am J Gastroenterol, 91 (1996), pp. 1571-1578
[17.]
S.L. Jowett, C.J. Seal, J.R. Barton, M.R. Welfare.
Short inflammatory bowel disease questionnaire is reliable and responsive to clinically important change in ulcerative colitis.
Am J Gastroenterol, 96 (2001), pp. 2921-2928
[18.]
M. Rose, H. Fliege, M. Hildebrandt, J. Korber, P. ArcK, A. Dignass, et al.
Validation of the new German translation version of the «Short inflammatory bowel disease questionnaire» (SIBDQ).
Z Gastroenterol, 38 (2000), pp. 277-286
[19.]
S.W. Han, W. Gregory, D. Nylander, A. Tanner, P. Trewby, R. Barton, et al.
The SIBDQ: further validation in ulcerative colitis patients.
Am J Gastroentereol, 95 (2000), pp. 145-151
[20.]
M.J. Alcalá, F. Casellas, L. Prieto, J-R. Malagelada.
Development of a short questionnaire for quality of life specific for inflammatory bowel disease.
Gastroenterology, 120 (2001), pp. A450
[21.]
D.A. Drossman, D.L. Patrick, C.M. Mitchell, E.A. Zagami, M.I. Appelbaum.
Health related quality of life in inflammatory bowel disease: functional status and patient worries and concerns.
Dig Dis Sci, 34 (1989), pp. 1379-1386
[22.]
D.A. Drossman, J. Leserman, Z. Li, C.M. Mitchell, E.A. Zagami, D.L. Patrick.
The rating form of IBD patient concerns: a new measure of health status.
Psychosom Med, 53 (1991), pp. 701-712
[23.]
R.G. Farmer, K.A. Easley, J.M. Farmer.
Quality of life assessmente by patiens with inflammatory bowel disease.
Cleve Clin J Med, 59 (1992), pp. 35-42
[24.]
J. López Vivancos, F. Casellas, X. Badía, J. Vilaseca, J-R. Malagelada.
Validation of the Spanish version of the Inflammatory Bowel Disease Questionnaire in ulcerative colitis and Crohn’s disease.
Digestion, 60 (1999), pp. 274-280
[25.]
F. Casellas, J. López Vivancos, X. Badía, J. Vilaseca, J-R. Malagelada.
Impact of surgery for Crohn’s disease on health-related quality of life.
Am J Gastroenterol, 95 (2000), pp. 177-182
[26.]
F. Casellas, J. López Vivancos, X. Badía, J. Vilaseca, J-R. Malagelada.
Influence of inflammatory bowel disease on different dimensions of quality of life.
Eur J Gastroenterol Hepatol, 13 (2001), pp. 567-572
[27.]
F. Casellas, J. López Vivancos, A. Casado, J-R. Malagelada.
Factors affecting health related quality of life of patients with inflammatory bowel disease.
Quality Life Research, 11 (2002), pp. 775-781
[28.]
F. Casellas, J. López Vivancos, J-R. Malagelada.
Experiencia previa y calidad de vida en pacientes con enfermedad inflamatoria intestinal durante los brotes de actividad.
Rev Esp Enferm Dig, 95 (2003), pp. 471-475
[29.]
D.A. Drossman, J. Leserman, C.M. Mitchell, Z. Li, E.A. Zagami, D.L. Patric.
Health status, and health care use in persons with inflammatory bowel disease. A national sample.
Dig Dis Sci, 36 (1991), pp. 1746-1755
[30.]
M. Vergara, F. Casellas, X. Badía, J.R. Malagelada.
Assessing the quality of life of household members of patients with inflammatory bowel disease: development and validation of a specific questionnaire.
Am J Gastroenterol, 97 (2002), pp. 1429-1437
[31.]
I. Van der Eijk, H. Sixma, T. Smeets, F. Tavarela, S. Odes, S. Montague, et al.
Quality of health care in inflammatory bowel disease: development of a reliable questionnaire (QUOTEIBD) and first results.
Am J Gastroenterol, 96 (2001), pp. 3329-3336
[32.]
F. Casellas, G. Fontanet, N. Borruel, J.R. Malagelada.
Opinión de los pacientes con enfermedad inflamatoria intestinal sobre la atención sanitaria recibida.
Gastroenterol Hepatol, 24 (2001), pp. 109
[33.]
N.J. Talley, V. Stanghellini, R.C. Heading, K.L. Koch, J.R. Malagelada.
Tytgat GNJ. Functional gastroduodenal disorders.
Gut, 45 (1999), pp. 37-42
[34.]
M. Thumshirn.
Pathophysiology of functional dyspepsia.
Gut, 51 (2002), pp. 63-66
[35.]
B. Coffin, F. Azpiroz, F. Guarner, J.R. Malagelada.
Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia.
Gastroenterology, 107 (1994), pp. 1345-1351
[36.]
F. Mearin, M. Cucala, F. Azpiroz, J.R. Malagelada.
The origin of symptoms on the brain-gut axis in functional dyspepsia.
Gastroenterology, 101 (1991), pp. 999-1006
[37.]
J.M. Piqué.
Perspectivas de futuro en la dispepsia funcional: nuevos tratamientos en el horizonte.
Gastroenterol Hepatol, 23 (2000), pp. 47-52
[38.]
N.J. Talley.
Review article: dyspepsia: how to manage and how to treat?.
Aliment Pharmacol Ther, 16 (2002), pp. 95-104
[39.]
B.C. Delaney, M.A. Innes, J. Deeks, S. Wilson, M.K. Cooner, P. Moayyedi, et al.
Initial management strategies for dyspepsia.
Cochrane Database Syst Rev, 3 (2001), pp. CD001961
[40.]
B.M.R. Spiegel, N.B. Vakil, J.J. Ofman.
Dyspepsia management in primary care: a decision analysis of competing strategies.
Gastroenterology, 122 (2002), pp. 1270-1285
[41.]
U. Ladabaum, W.D. Chey, J.M. Scheiman, A. Fendrick.
Reapparaisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimizaling analysis.
Aliment Pharmacol Ther, 16 (2002), pp. 1491-1501
[42.]
P. Moayyedi, J. Masson.
Clinical and economic consequences of dyspepsia in the community.
Gut, 50 (2002), pp. 10-12
[43.]
B. Fischler, J. Tack, V. Gucht, I.V. Shkedy, P. Persoons, D. Broekaert, et al.
Heterogeneity of symptom pattern, psychosocial factors and pathophysiological mechanisms in severe functional dyspepsia.
Gastroenterology, 124 (2003), pp. 903-910
[44.]
F. Bamfi, A. Olivieri, F. Arpinelli.
Measuring quality of life in dyspeptic patients: development and validation of a new specific health status questionnaire. Final report from the italian QPD project involving 4000 patients.
Am J Gastroenterol, 94 (1999), pp. 730-738
[45.]
C. Martin, P. Marquis, S. Bonfils.
A quality of life questionnare adapted to duodenal ulcer therapeutic trials.
Scand J Gastroenterol, 29 (1994), pp. 40-43
[46.]
S.J.O. Van Zanten, KMAJ Tytgat, P.T. Pollak.
Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and H pylori associated gastritis?.
J Clin epidemiol, 46 (1993), pp. 273-279
[47.]
N.J. Talley, M. Haque, J.W. Wyeth, N.H. Stace, G.N.J. Tytgat, V. Stanghellini, et al.
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index.
Aliment Pharmacol Ther, 13 (1999), pp. 225-235
[48.]
N.J. Talley, M. Verlinden, M. Jones.
Quality of life in functional dyspepsia: responsiveness of the Nepean Dyspepsia Index and development of a new 10-item short form.
Aliment Pharmacol Ther, 15 (2001), pp. 207-216
[49.]
D.H. Kuykendall, L. Rabeneck, C.J.M. Campbell, N.P. Wray.
Dyspepsia: how should we measure it?.
J Clin Epidemiol, 51 (1988), pp. 99-106
[50.]
K.F. Cook, L. Rabeneck, C.J. Campbell, N.P. Wray.
Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial.
J Clin Epidemiol, 52 (1999), pp. 381-392
[51.]
L. Rabeneck, K.F. Cook, K. Wristers, J. Souchek, T. Menke, N.P. Wray.
SODA (Severity of Dyspepsia Assessment): a new effective outcome meausre for dyspepsia-related health.
J Clin Epidemiol, 54 (2001), pp. 755-765
[52.]
E.M. El-Omar, S. Banerjee, A. Wirz, K.E. McColl.
The Glasgow dyspepsia severity score - a tool for the global measurement of dyspepsia.
Eur J Gastroenterol Hepatol, 8 (1996), pp. 967-971
[53.]
J. Monés, A. Adán, J.S. López, M. Artés.
Validación de la versión española de la Glasgow Dyspepsia Sverity Score.
Rev Esp Enf Dig, 93 (2001), pp. 164-169
[54.]
M. Ruiz, F. Villasante, V. González-Lara, F. León, C. González, M. Crespo, et al.
Cuestionario sobre calidad de vida asociada a dispepsia. Adaptación española y validación del cuestionario Dyspepsia Related Health Scale.
Med Clin (Barc), 117 (2001), pp. 567-573
[55.]
J. Goldman, D.F. Conrad, C. Ley, D. Halperin, M. Luz, R. Villacorta, et al.
Validation of Spanish language dyspepsia questionnaire.
Dig Dis Sci, 47 (2002), pp. 624-640
[56.]
J. Monés, S. Adán, J.L. Segú, J.S. López, M. Artés, T. Guerrero.
Quality of life in functional dyspepsia.
Dig Dis Sci, 47 (2002), pp. 20-26
[57.]
L. Rabeneck, K. Wristers, C. Campbell, J. Souchek, T. Menke, N.P. Wray.
Sociodemographics, general health and psychologic health in uninvestigated dyspepsia: a comparison of public and private patients.
J Clin Gastroenterol, 34 (2002), pp. 516-522
[58.]
L. Rabeneck, K. Wristers, J. Souchek, E. Ambriz.
Impact of upper endoscopy on satisfaction in patients with previously uninvestigated dyspepsia.
Gastrointest Endosc, 57 (2003), pp. 295-299
[59.]
A.M. Accarino, F. Azpiroz, J.R. Malagelada.
Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome.
Gastroenterology, 108 (1995), pp. 636-643
[60.]
W.G. Thompson, G.F. Longstreth, D.A. Drossman, K.W. Heaton, E.J. Irvine, S.A. Müller-Lissner.
Functional bowel disorders and functional abdominal pain.
Gut, 45 (1999), pp. 1143-1147
[61.]
M. Boivin.
Socioeconomic impact of irritable bowel syndrome in Canada.
Can J Gastroenterol, 15 (2001), pp. 8-11
[62.]
D.B. Silk.
Impact of irritalbe bowel syndrome on personal relationships and working practices.
Eur J Gastroenterol, 13 (2001), pp. 1327-1332
[63.]
H.B. El-Serag, K. Olden, D. Bjorkman.
Health-related quality of life among persons with irritable bowel syndrome: a systematic review.
Aliment Pharmacol Ther, 16 (2002), pp. 1171-1185
[64.]
W.E. Whitehead, C.K. Burnett, E.W. Cook III, E. Taub.
Impact of irritable bowel syndrome on quality of life.
Dig Dis Sci, 41 (1996), pp. 2248-2253
[65.]
L. Frank, L. Kleinman, A. Rentz, G. Ciesla, J.J. Kim, C. Zacker.
Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases.
Clin Ther, 24 (2002), pp. 675-689
[66.]
E.J. Irvine, M. Donnelly.
Quality of life is comparably impaired in patients with ulcerative colitis and irritable bowel syndrome.
Gastroenterology, 106 (1994), pp. A517
[67.]
M. O’Sullivan, N. Mahmud, E. Lovett, D. Kelleher, C.A. O’Morain.
Impaired quality of life in irritable bowel syndrome as compared to organic bowel disease.
Gastroenterology, 112 (1997), pp. A801
[68.]
M.A. O’Sullivan, N. Mahmud, D.P. Kelleher, E. Lovett, C.A. O’Morain.
Patient knowledge and educational needs in inflammatory bowel disease.
Eur J Gastroenterol Hepatol, 12 (2000), pp. 39-43
[69.]
F.X. Li, S.B. Patten, R.J. Hilsden, L.R. Sutherland.
Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta.
Can J Gastroenterol, 17 (2003), pp. 259-263
[70.]
L. Chang, M. Heitkemper.
Gender differences in irritable bowel syndrome.
Gastroenterology, 123 (2002), pp. 1686-1701
[71.]
X. Badía, F. Mearin, A. Balboa, E. Baro, E. Caldwell, M. Cucala, et al.
Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.
Pharmacoeconomics, 20 (2002), pp. 749-758
[72.]
F. Mearin, A. Balboa, X. Badía, E. Baro, E. Caldwell, M. Cucala, et al.
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype.
Eur J Gastroenterol Hepatol, 15 (2003), pp. 165-172
[73.]
F. Creed, J. Ratcliffe, L. Fernández, B. Tomenson, S. Palmer, C. Rigby, et al.
Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.
Ann Intern Med, 134 (2001), pp. 860-868
[74.]
B.A. Hahn, L.J. Kirchdoerfer, S. Fullerton, E. Mayer.
Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome.
Aliment Pharmacol Ther, 11 (1997), pp. 547-552
[75.]
B.A. Hahn, L.J. Kirchdoerfer, S. Fullerton, E. Mayer.
Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life.
Aliment Pharmacol Ther, 11 (1997), pp. 553-559
[76.]
B.A. Hahn, S. Yan, S. Strassels.
Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.
Digestion, 60 (1999), pp. 77-81
[77.]
D.L. Patrick, D.A. Drossman, I.O. Frederick, J. DiCesare, K.L. Puder.
Quality of life in persons with irritable bowel syndrome: development and validation of a new measure.
Dig Dis Sci, 43 (1998), pp. 400-411
[78.]
D.A. Drossman, D.L. Patrick, W.E. Whitehead, B.B. Toner, N.E. Diamant, Y. Hu, et al.
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
Am J Gastroenterol, 95 (2000), pp. 999-1007
[79.]
A.D. Sperber, S. Carmel, Y. Atzmon, I. Weisberg, Y. Shalit, L. Neumann.
Use of the functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel disease syndrome and fibromyalgia.
Am J Gastroenterol, 95 (2000), pp. 995-998
[80.]
E. Wong, G. Guyatt, D.J. Cook, L.E. Griffith, E.J. Irvine.
Development of a questionnaire to measure quality of life in patients with irritable bowel syndrome.
Eur J Surg, (1998), pp. 50-56
[81.]
D.A. Drossman, W.E. Whitehead, B.B. Toner, N. Diamant, Y.J. Hu, S.I. Bangdiwala, et al.
What determines severity among patients with painful functional bowel disorders?.
Am J Gastroenterol, 95 (2000), pp. 974-980
[82.]
X. Badía, M. Herdman, F. Mearin, I. Pérez.
Adaptación al español del cuestionario IBSQOL para la medición de la calidad de vida en pacientes con síndrome del intestino irritable.
Rev Esp Enferm Dig, 92 (2000), pp. 637-643
[83.]
S. Muller-Lissner, G. Koch, N.J. Talley, D. Drossman, P. Rueegg, C. Dunger-Baldauf, et al.
Subject’s Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials.
J Clin Epidemiol, 56 (2003), pp. 310-316
[84.]
M. Hollenz, M. Stolte, J. Labenz.
Prevalence of gastro-oesophageal reflux disease in general practice.
Dtsch Med Wochenschr, 10 (2002), pp. 1007-1012
[85.]
J.J. Ofmann.
The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease.
Am J Gastroenterol, 98 (2003), pp. 8-14
[86.]
N.I. McDougall, B.T. Johnston, F. Kee.
Natural history of reflux oesophagitis: a 10 year follow up of its effect onpatients symptomatology an quality of life.
Gut, 38 (1996), pp. 481-486
[87.]
P. Wahlqvist.
Symptoms of gastroesophageal reflux disease, perceived productivity and health-related quality of life.
Am J Gastroenterol, 96 (2001), pp. 57-61
[88.]
B. Kaplan-Machlis, G.E. Spiegler, D.A. Revicki.
Health-related quality of life in primary care patients with gastroesophageal reflux disease.
Ann Pharmacother, 33 (1999), pp. 1032-1036
[89.]
D.A. Revicki, M. Wood, P.N. Maton, S. Sorensen.
The impact of gastroesophageal reflux disease on health-related quality of life.
Am J Med, 104 (1998), pp. 252-258
[90.]
E. Dimenas, H. Glise, B. Hallerback, H. Hernqvist, J. Svedlund, I. Wiklund.
Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?.
Scand J Gastroenterol, 28 (1993), pp. 681-687
[91.]
C. Farup, L. Kleinman, S. Sloan, D. Ganoczy, E. Chee, C. Lee, et al.
The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life.
Arch Intern Med, 161 (2001), pp. 45-52
[92.]
M.A. Eloubeidi, D. Provenzale.
Health-related quality of life and severity of symptoms in patients with Barrett’s esophagus and gastroesophageal reflux disease patients without Barrett’s esophagus.
Am J Gastroenterol, 95 (2000), pp. 1881-1887
[93.]
R.G.P. Watson, T.C.K. Tham, B.T. Johnston, N.I. McDougall.
Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux - «the sensitive esophagus».
Gut, 40 (1997), pp. 587-590
[94.]
S. Sacher-Huvelin, J. Gournay, M. Amouretti, P. Marquis, S. Bruley des Varannes, J.P. Galmiche.
Acid-sensitive esophagus: natural history and effect on the quality of life. Comparison with gastroesophageal reflux.
Gastroenterol Clin Biol, 24 (2000), pp. 903-905
[95.]
J. Svedlund, I. Sjodin, G. Dotevall.
GSRS-A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease.
Dig Dis Sci, 33 (1988), pp. 129-134
[96.]
D.A. Revicki, M. Wood, I. Wiklund.
Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease.
Qual Life Res, 7 (1998), pp. 75-83
[97.]
N.J. Talley, S. Fullerton, O. Junghard, I. Wiklund.
Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments.
Am J Gastroenterol, 96 (2001), pp. 1998-2004
[98.]
G.R. Locke, N.J. Talley, A.L. Weaver, A.R. Zinsmeister.
A new questionnaire for gastroesophageal reflux disease.
Mayo Clin Proc, 69 (1994), pp. 539-547
[99.]
C.J. Allen, K. Parameswaran, J. Belda, M. Anvari.
Reproducibility, validity and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease.
Dis Esophagus, 13 (2000), pp. 265-270
[100.]
P. Pare, F. Meyer, D. Armstrong, M. Pyzyk, D. Pericak, R. Goeree.
Validation of the GSFQ, a self-administered symptom frequence questionnaire for patients with gastroesophageal reflux disease.
Can J Gastroenterol, 17 (2003), pp. 307-312
[101.]
V. Velanovich, S.R. Vallance, J.R. Gusz.
Quality of life scale for gastroesophageal reflux disease.
J Am Coll Surg, 183 (1996), pp. 217-224
[102.]
V. Velanovich.
Comparison of generic SF-36 vs disease-specific GERD-HRQL quality-of-life scales for gastroesophageal reflux disease.
J Gastrointest Surg, 2 (1998), pp. 141-145
[103.]
L. Kleinman, N.K. Leidy, J. Crawley, A. Bonomi, P. Schoenfeld.
A comparative trial of paper-and-pencil versus computer administration of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire.
Med Care, 39 (2001), pp. 181-189
[104.]
P. Wahlqvist, J. Carlsson, N.O. Stalhammar, I. Wiklund.
Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD). Results from a cross sectional study.
Value Health, 5 (2002), pp. 106-113
[105.]
H.H. Colwell, S.D. Mathias, D.J. Pasta, J.M. Henning, R.H. Hunt.
Development of a health-related quality-of-life questionnaire for individuals with gastroesophageal reflux disease.
Dig Dis Sci, 44 (1999), pp. 1376-1383
[106.]
S.D. Mathias, H.H. Colwell, D.P. Miller, D.J. Pasta, J.M. Henning, J.J. Ofman.
Health-related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine.
Dig Dis Sci, 46 (2001), pp. 2416-2423
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
